Abstract is: Ibrahim Ibrahim Abubakar FFPH FRCPE FRCP FMedSci is a British-Nigerian epidemiologist who is Professor in Infectious Disease Epidemiology at University College London and Dean of the .
| human | Q5 |
| P6178 | Dimensions author ID | 01214465165.19 |
| P227 | GND ID | 1100080953 |
| P2671 | Google Knowledge Graph ID | /g/11c1pm8_hn |
| P1960 | Google Scholar author ID | GlvTmVIAAAAJ |
| P244 | Library of Congress authority ID | nb2007028106 |
| P691 | NL CR AUT ID | xx0272513 |
| P1207 | NUKAT ID | n2007085266 |
| P496 | ORCID iD | 0000-0002-0370-1430 |
| P1153 | Scopus author ID | 6602338051 |
| P214 | VIAF ID | 311255404 |
| P69 | educated at | Norwich Medical School | Q17017360 |
| P108 | employer | Royal Free London NHS Foundation Trust | Q7374195 |
| MRC Clinical Trials Unit | Q30280318 | ||
| University College London | Q193196 | ||
| University of East Anglia | Q1045828 | ||
| P734 | family name | Abubakar | Q36963365 |
| Abubakar | Q36963365 | ||
| Abubakar | Q36963365 | ||
| P101 | field of work | tuberculosis | Q12204 |
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | epidemiologist | Q12765408 |
| university teacher | Q1622272 | ||
| P21 | sex or gender | male | Q6581097 |
| Q42428982 | 'Pre-entry screening for tuberculosis' commentary: authors' response |
| Q56794180 | A Case-Control Study of Drinking Water and Dairy Products in Crohn's Disease--Further Investigation of the Possible Role of Mycobacterium avium paratuberculosis |
| Q41529893 | A collaborative strategy to tackle tuberculosis in England |
| Q33940634 | A controlled trial of the knowledge impact of tuberculosis information leaflets among staff supporting substance misusers: pilot study |
| Q114979065 | A feasibility study evaluating the uptake, effectiveness and acceptability of routine screening of pregnant migrants for latent tuberculosis infection in antenatal care: a research protocol |
| Q33862689 | A geographically-restricted but prevalent Mycobacterium tuberculosis strain identified in the West Midlands Region of the UK between 1995 and 2008. |
| Q40481466 | A multi-perspective service evaluation exploring tuberculosis contact screening attendance among adults at a North London hospital. |
| Q37133811 | A systematic review of analytical observational studies investigating the association between cardiovascular disease and drinking water hardness |
| Q36931054 | A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food |
| Q44682386 | A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis |
| Q33810858 | Access to invasive procedures can be audited by ethnic group |
| Q35753808 | Accuracy of Probabilistic Linkage Using the Enhanced Matching System for Public Health and Epidemiological Studies |
| Q54234294 | Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening. |
| Q40063066 | Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study |
| Q38098042 | Active case finding for tuberculosis among high-risk groups in low-incidence countries |
| Q36833723 | Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test |
| Q51529128 | Advancing global programmatic management of latent tuberculosis infection for at risk populations. |
| Q50071702 | Aiming for zero tuberculosis transmission in low-burden countries |
| Q91509371 | App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis |
| Q57277994 | Assessing an outbreak of tuberculosis in an English college population |
| Q57277993 | Assessing the effect of foreign travel and protection by BCG vaccination on the spread of tuberculosis in a low incidence country, United Kingdom, October 2008 to December 2009 |
| Q36063067 | Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study |
| Q57277995 | Authors' reply |
| Q57278001 | Authors' reply |
| Q46361464 | Authors' reply to Turner and colleagues. |
| Q36307004 | BCG vaccination in England since 2005: a survey of policy and practice |
| Q51812819 | BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. |
| Q54626179 | BCG vaccination: a long-lasting protection against tuberculosis?--Authors' reply. |
| Q40820050 | CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection |
| Q48840756 | Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease |
| Q43010729 | Can routine laboratory data guide empirical prescribing? |
| Q57278011 | Candidaemia in a large teaching hospital: a clinical audit |
| Q40164786 | Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences |
| Q42268043 | Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. |
| Q28395800 | Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 |
| Q58700382 | Changes in health in the countries of the UK and 150 English Local Authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 |
| Q40273972 | Clinical trial research in focus: overcoming barriers in MDR-TB clinical trials |
| Q48181298 | Comparing different technologies for active TB case-finding among the homeless: a transmission-dynamic modelling study. |
| Q39636742 | Controversies and unresolved issues in tuberculosis prevention and control: a low-burden-country perspective |
| Q26777926 | Data for action: collection and use of local data to end tuberculosis |
| Q39396662 | Decreasing incidence of tuberculosis among heterosexuals living with diagnosed HIV in England and Wales |
| Q35740443 | Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation |
| Q24791687 | Development and evaluation of a hand held computer based on-call pack for health protection out of hours duty: a pilot study |
| Q54210805 | Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort. |
| Q38520964 | Diagnosis and Management of Latent Tuberculosis Infection |
| Q57277990 | Diagnosis of active and latent tuberculosis: summary of NICE guidance |
| Q48568233 | Diagnostic accuracy of digital chest radiography for pulmonary tuberculosis in a UK urban population |
| Q27321528 | Digital health for the End TB Strategy: developing priority products and making them work |
| Q56395612 | Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing |
| Q40036449 | Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria. |
| Q100737298 | Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings |
| Q43696827 | Do we need bacteriological confirmation of cure in uncomplicated tuberculosis? |
| Q90714209 | Drug misuse, tobacco smoking, alcohol and other social determinants of tuberculosis in UK-born adults in England: a community-based case-control study |
| Q35218108 | Drug-resistance mechanisms and tuberculosis drugs |
| Q34266001 | Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs |
| Q30428762 | Drug-resistant tuberculosis: time for visionary political leadership |
| Q39302030 | Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study |
| Q57278008 | EXTENSIVE TRANSMISSION OF MYCOBACTERIUM TUBERCULOSIS AMONG CHILDREN ON A SCHOOL BUS |
| Q46164900 | Economic crisis and communicable disease control in Europe: a scoping study among national experts |
| Q22242062 | Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis |
| Q37681211 | Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial |
| Q28087078 | Effect of study design and setting on tuberculosis clustering estimates using Mycobacterial Interspersed Repetitive Units-Variable Number Tandem Repeats (MIRU-VNTR): a systematic review |
| Q51177194 | Effect of water hardness on cardiovascular mortality: an ecological time series approach. |
| Q56972829 | Effects of distance to treatment centre and case load upon tuberculosis treatment completion |
| Q49348492 | Eliminating tuberculosis in low-burden countries |
| Q30209590 | Epidemiology and clinical management of Legionnaires' disease |
| Q46533407 | Epidemiology and treatment outcome of childhood tuberculosis in England and Wales: 1999-2006. |
| Q28391248 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015 |
| Q39197665 | Estimating the tuberculosis burden in resource-limited countries: a capture-recapture study in Yemen |
| Q45173174 | Estimating tuberculosis burden and reporting in resource-limited countries: a capture-recapture study in Iraq |
| Q26823223 | European union standards for tuberculosis care |
| Q57278012 | Evaluating compliance with national guidelines for the clinical, laboratory and public health management of tuberculosis in a low-prevalence English district |
| Q40406569 | Evaluating knowledge gain from TB leaflets for prison and homeless sector staff: the National Knowledge Service TB pilot |
| Q36221287 | Evaluation of immigrant tuberculosis screening in industrialized countries |
| Q40015585 | Evidence for a national problem: continued rise in tuberculosis case numbers in urban areas outside London. |
| Q57278006 | Extensive transmission of Mycobacterium tuberculosis from 9 year old child with pulmonary tuberculosis and negative sputum smear |
| Q44812188 | Extensively drug-resistant tuberculosis in the UK: 1995 to 2007. |
| Q34356722 | Factors associated with being lost to follow-up before completing tuberculosis treatment: analysis of surveillance data. |
| Q43236850 | Foreign travel associated with increased sexual risk-taking, alcohol and drug use among UK university students: a cohort study |
| Q37767908 | Foreign travel, casual sex, and sexually transmitted infections: systematic review and meta-analysis. |
| Q59664710 | Global patterns of mortality in international migrants: a systematic review and meta-analysis |
| Q43338313 | Global perspectives for prevention of infectious diseases associated with mass gatherings |
| Q30358426 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 |
| Q24170269 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition |
| Q21034169 | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q30409179 | Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q30410700 | Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
| Q43226974 | HIV infection and the transmission of tuberculosis |
| Q38391395 | Health status and quality of life in tuberculosis |
| Q64069991 | Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study |
| Q51782901 | Hepatitis C virus treatment as prevention in people who inject drugs. |
| Q51549600 | High levels of neurological involvement but low mortality in miliary tuberculosis: a 6-year case-series from the UK. |
| Q30061805 | High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study |
| Q39404058 | How does the level of BCG vaccine protection against tuberculosis fall over time? |
| Q39468978 | How should I interpret an interferon gamma release assay result for tuberculosis infection? |
| Q56889339 | Humanitarian disaster for Rohingya refugees: impending natural hazards and worsening public health crises |
| Q37739245 | Immigrant Arrival and Tuberculosis among Large Immigrant- and Refugee-Receiving Countries, 2005-2009. |
| Q41387994 | Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland. |
| Q59798434 | Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants |
| Q64089358 | Improving engagement with healthcare in hepatitis C: a randomised controlled trial of a peer support intervention |
| Q34239305 | Incidence and risk factors for drug intolerance and association with incomplete treatment for tuberculosis: analysis of national case registers for England, Wales and Northern Ireland, 2001-2010. |
| Q45899306 | Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. |
| Q31154420 | Increasing antituberculosis drug resistance in the United Kingdom: analysis of National Surveillance Data |
| Q33719852 | Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006 |
| Q38156543 | Infectious causes of microcephaly: epidemiology, pathogenesis, diagnosis, and management |
| Q38600339 | Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014. |
| Q46294890 | Insertion site mapping for repeated elements in Mycobacterium tuberculosis |
| Q35416692 | Inter-rater agreement in defining chemical incidents at the National Poisons Information Service, London |
| Q26752616 | Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review |
| Q35066541 | Investigating transmission of Mycobacterium bovis in the United Kingdom in 2005 to 2008. |
| Q57278009 | Investigating tuberculosis trends in England |
| Q39789746 | Investigating urban-rural disparities in tuberculosis treatment outcome in England and Wales |
| Q36883714 | Leprosy in England and Wales 1953-2012: surveillance and challenges in low incidence countries |
| Q123987893 | Long-Term Outcomes of SARS-CoV-2 Variants and Other Respiratory Infections: Evidence from the Virus Watch Prospective Cohort in England |
| Q35787450 | Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries |
| Q42715629 | Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement |
| Q27693348 | Managing pulmonary nontuberculous mycobacterial infection. time for a patient-centered approach |
| Q39149278 | Migration and tuberculosis in the UK: targeting screening for latent infection to those at greatest risk of disease |
| Q36689518 | Mind the gap: TB trends in the USA and the UK, 2000-2011 |
| Q36361918 | Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control |
| Q31117859 | Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. |
| Q63362680 | Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era |
| Q35980151 | Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru |
| Q38991491 | Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004-12: a time series analysis |
| Q38199573 | New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects |
| Q111771574 | OP39 Protection by BCG Against Tuberculosis: Systematic Review and Meta-Regression Analysis |
| Q111771561 | OP43 A case control study of social determinants of tuberculosis risk in white UK-born adults in england |
| Q38664853 | Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK. |
| Q113309231 | Optima TB: A tool to help optimally allocate tuberculosis spending |
| Q24800071 | Outcome after acute myocardial infarction: a comparison of patients seen by cardiologists and general physicians |
| Q35996548 | Outcomes analysis of new entrant screening for active tuberculosis in Heathrow and Gatwick airports, United Kingdom 2009/2010. |
| Q104494828 | Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort study |
| Q26777838 | Peer Support Workers in Health: A Qualitative Metasynthesis of Their Experiences |
| Q36933285 | Perceived causes of sporadic cryptosporidiosis and their relation to sources of information |
| Q35454365 | Poor uptake of primary healthcare registration among recent entrants to the UK: a retrospective cohort study |
| Q50112567 | Post-migration follow-up of migrants at risk of tuberculosis |
| Q26830440 | Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis |
| Q40741555 | Prevalence of and risk factors for active tuberculosis in migrants screened before entry to the UK: a population-based cross-sectional study |
| Q24246356 | Prevention and treatment of cryptosporidiosis in immunocompromised patients |
| Q58791540 | Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study |
| Q52589440 | Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions. |
| Q34325944 | Prospective evaluation of a complex public health intervention: lessons from an initial and follow-up cross-sectional survey of the tuberculosis strain typing service in England |
| Q38171263 | Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials |
| Q56830527 | Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? |
| Q36011261 | Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012. |
| Q37878570 | Quality assessment of capture-recapture studies in resource-limited countries |
| Q91876395 | Quantitative IFN-γ Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis. A Prospective Cohort Study |
| Q38122639 | Raising standards in UK TB control: introducing cohort review |
| Q37156356 | Recent TB transmission, clustering and predictors of large clusters in London, 2010-2012: results from first 3 years of universal MIRU-VNTR strain typing |
| Q33791982 | Recent household transmission of tuberculosis in England, 2010-2012: retrospective national cohort study combining epidemiological and molecular strain typing data |
| Q51725283 | Reply to Kernodle and von Reyn. |
| Q38827332 | Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs |
| Q51558627 | Respiratory co-morbidities in people with HIV. |
| Q39037971 | Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis |
| Q42243733 | Reversing the tide of the UK tuberculosis epidemic |
| Q43849121 | Risk factors for recurrent tuberculosis in England and Wales, 1998-2005. |
| Q56794162 | Risk factors for the misdiagnosis of tuberculosis in the UK, 2001–2011: TABLE 1 |
| Q57277991 | Risk of Tuberculosis in Pregnancy |
| Q37584591 | Role of interferon-gamma release assays in healthcare workers |
| Q58880867 | S57 Diabetes and latent tuberculosis infection: nested case-control study within the PREDICT cohort |
| Q106194800 | S58 TB co-infection is associated with poor survival among HIV infected patients in england and wales |
| Q44854033 | School-based sex education is associated with reduced risky sexual behaviour and sexually transmitted infections in young adults |
| Q35024697 | Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis |
| Q46506308 | Sex, drugs and sexually transmitted infections in British university students |
| Q43285302 | Sexual behaviour, drugs and alcohol use of international students at a British university: a cross-sectional survey |
| Q41444380 | Shortening treatment of tuberculosis: lessons from fluoroquinolone trials. |
| Q64058751 | Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial |
| Q47874483 | Standard operating procedures for tuberculosis care |
| Q34410134 | Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. |
| Q57277985 | Surveillance for tuberculosis |
| Q44147264 | Surveillance of air-travel-related tuberculosis incidents, England and Wales: 2007-2008. |
| Q44281749 | Survey of tuberculosis incidents in hospital healthcare workers, England and Wales, 2005. |
| Q40273960 | Sustaining tuberculosis decline in the UK. |
| Q99727201 | Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: An observational cohort study |
| Q38135954 | Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis |
| Q38465643 | Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis |
| Q39988887 | TB in healthcare workers in the UK: a cohort analysis 2009-2013. |
| Q56396440 | Tackling the spread of drug-resistant tuberculosis in Europe |
| Q46719231 | Tackling viral haemorrhagic fever in Africa |
| Q46179617 | The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis |
| Q91802918 | The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials |
| Q62488186 | The UCL-Lancet Commission on Migration and Health: the health of a world on the move |
| Q44260096 | The association between HIV and antituberculosis drug resistance |
| Q45737830 | The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results. |
| Q41986442 | The duration of protection of school-aged BCG vaccination in England: a population -based case-control study |
| Q34533596 | The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 |
| Q36225886 | The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003. |
| Q30226524 | The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence |
| Q38264887 | The impact of genomics on public health practice |
| Q36226655 | The indirect cost due to pulmonary Tuberculosis in patients receiving treatment in Bauchi State-Nigeria |
| Q45763773 | The influence of socio-economic deprivation on tuberculosis treatment delays in England, 2000-2005. |
| Q39017288 | The prospective evaluation of the TB strain typing service in England: a mixed methods study |
| Q37693149 | The provider cost of treating tuberculosis in Bauchi State, Nigeria |
| Q37581400 | The risk to infants from nosocomial exposure to tuberculosis |
| Q28478546 | The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident |
| Q38729690 | The transmission of Mycobacterium tuberculosis in high burden settings |
| Q35966541 | Towards better guidance on caseload thresholds to promote positive tuberculosis treatment outcomes: a cohort study |
| Q54215075 | Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium. |
| Q51535427 | Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC). |
| Q42225346 | Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing |
| Q58058431 | Treatment of Latent Tuberculosis Infection |
| Q36388002 | Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis |
| Q34433190 | Treatment of latent tuberculosis infection: a network meta-analysis |
| Q30428738 | Treatment of pulmonary tuberculosis |
| Q42244124 | Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. |
| Q38861620 | Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap. |
| Q37898887 | Tuberculosis and HIV co-infection in European Union and European Economic Area countries |
| Q45185093 | Tuberculosis and HIV co-infection in healthcare workers in England and Wales, 1999-2005. |
| Q37698753 | Tuberculosis and air travel: a systematic review and analysis of policy |
| Q40587832 | Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices |
| Q38093325 | Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts |
| Q37796429 | Tuberculosis contact investigation in low prevalence countries: a European consensus |
| Q38002002 | Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities |
| Q43128686 | Tuberculosis in UK prisoners: a challenge for control |
| Q37433451 | Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland |
| Q56397879 | Tuberculosis in prisons: anatomy of global neglect |
| Q56398244 | Tuberculosis in the UK--time to regain control |
| Q39818213 | Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice |
| Q40128150 | Tuberculosis treatment outcomes among disadvantaged patients in India |
| Q40834854 | Tuberculosis--diagnosis, management, prevention, and control: summary of updated NICE guidance |
| Q58592878 | Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study |
| Q38858739 | UCL-Lancet Commission on Migration and Health |
| Q57278000 | UK immigrant screening is inversely related to regional tuberculosis burden |
| Q52682616 | UK's role in global health research innovation. |
| Q42938895 | Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment |
| Q57277989 | Universal HIV testing in London tuberculosis clinics: a cluster randomised controlled trial |
| Q59808457 | Universal health coverage for refugees and migrants in the twenty-first century |
| Q39302041 | Uptake of neonatal BCG vaccination in England: performance of the current policy recommendations |
| Q111896781 | Use of targeted mobile X-ray screening and computer-aided detection software to identify tuberculosis among high-risk groups in Romania: descriptive results of the E-DETECT TB active case-finding project |
| Q47108961 | Using peer advocates to improve access to services among hard-to-reach populations with hepatitis C: a qualitative study of client and provider relationships |
| Q57278004 | WHO publishes the third edition of guidelines for the prevention and control of air-travel-associated tuberculosis |
| Q43138519 | What is the role of urine dipstick testing in the management of UTI? |
| Q31098520 | Working conditions and tuberculosis mortality in England and Wales, 1890-1912: a retrospective analysis of routinely collected data |
| Q27304811 | World TB Day 2016: an interview with leading experts in tuberculosis research |